
HBsAg testing becomes central to selecting patients for bepirovirsen, a finite hepatitis B therapy given alongside NA treatment.

HBsAg testing becomes central to selecting patients for bepirovirsen, a finite hepatitis B therapy given alongside NA treatment.

HBsAg testing becomes central to selecting patients for bepirovirsen, a finite hepatitis B therapy given alongside NA treatment.

Drinking fell for the first time since COVID-19, but not for adults 50 to 64. Hepatologists explain what clinicians can do to close the gap.

As drinking declines, Stevan Gonzalez, MD, Frances Lee, MD, and Brian Lee, MD, on the lingering burden of alcohol-associated liver disease.

Heavy drinking rose >36% since 2018 among middle-aged adults. A hepatologist on screening, sex-specific thresholds, and pandemic effects.

Low-dose radiation therapy is gaining attention in the US for osteoarthritis and inflammatory pain, with clinicians citing anti-inflammatory effects.

Armstrong discusses the positive time-to-healing data from the phase 2 LEGenD-1 study, investigating anatomically targeted delivery of AMG0001.